PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10215105-0	1999	IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbits.	Daunorubicin	22-34	insulin-like growth factor I	Oryctolagus cuniculus	0-5	
10215105-2	1999	The occurrence of IGF-I was investigated in rabbits with experimentally daunorubicin-induced cardiomyopathy.	Daunorubicin	72-84	insulin-like growth factor I	Oryctolagus cuniculus	18-23	
10215105-5	1999	A significant increase in the IGF-I was found in the left heart ventricle in daunorubicin cardiomyopathy (152.9 +/- 10.0 ng/g vs 95.1 +/- 4.2 ng/g in the control group).	Daunorubicin	77-89	insulin-like growth factor I	Oryctolagus cuniculus	30-35	
10215105-9	1999	Furthermore, in skeletal muscle, the levels of IGF-I in the daunorubicin group (839.0 +/- 142.1 ng/g) were significantly higher in comparison with the control group (482.5 +/- 83.1 ng/g).	Daunorubicin	60-72	insulin-like growth factor I	Oryctolagus cuniculus	47-52	
10215105-11	1999	The level of IGF-I in the left ventricle in the daunorubicin group (but not in the control group) was significantly higher than that in the liver.	Daunorubicin	48-60	insulin-like growth factor I	Oryctolagus cuniculus	13-18	
10215105-14	1999	The increase in IGF-I concentrations in the left heart ventricle after the administration of daunorubicin may thus reflect possible autocrine/paracrine role of IGF-I in cardiomyopathy.	Daunorubicin	93-105	insulin-like growth factor I	Oryctolagus cuniculus	16-21	
10215105-14	1999	The increase in IGF-I concentrations in the left heart ventricle after the administration of daunorubicin may thus reflect possible autocrine/paracrine role of IGF-I in cardiomyopathy.	Daunorubicin	93-105	insulin-like growth factor I	Oryctolagus cuniculus	160-165